SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-21-017730
Filing Date
2021-11-12
Accepted
2021-11-12 08:09:04
Documents
14
Period of Report
2021-11-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp161684_8k.htm   iXBRL 8-K 26864
2 EXHIBIT 99.1 dp161684_ex9901.htm EX-99.1 11830
3 GRAPHIC image_001.jpg GRAPHIC 3655
  Complete submission text file 0000950103-21-017730.txt   219426

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crl-20211111.xsd EX-101.SCH 3007
5 XBRL LABEL FILE crl-20211111_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crl-20211111_pre.xml EX-101.PRE 22348
7 EXTRACTED XBRL INSTANCE DOCUMENT dp161684_8k_htm.xml XML 3500
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 211399786
SIC: 8731 Services-Commercial Physical & Biological Research